Editorial: Dysbiosis, obesity, and inflammation: interrelated phenomena causes or effects of metabolic syndrome?

Front Endocrinol (Lausanne). 2023 Oct 17:14:1265314. doi: 10.3389/fendo.2023.1265314. eCollection 2023.

Kaiser Wani^{1

2}, Shakilur Rahman^{3

4}, Hossam Draz⁵

¹ Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia.
² University Institute of Biotechnology, Chandigarh University, Mohali, India.
³ Department of Medical Elementology and Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India.
⁴ Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
⁵ Charles River Laboratories, Senneville, QC, Canada.

No abstract available

Keywords: dysbiosis; gut microbiota; inflammation; metabolic syndrome; metabolically healthy obese; obesity.

Publication types

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.